Role of Epigenetic Modification and Immunomodulation in a Murine Prostate Cancer Model.

about

Conditioning neoadjuvant therapies for improved immunotherapy of cancer.

P2860

Q45065285-4979E68F-A5D5-4820-A8D4-6D18CA962DB9

P2860

Role of Epigenetic Modification and Immunomodulation in a Murine Prostate Cancer Model.

Item

http://www.wikidata.org/entity/Q38730411

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Role of Epigenetic Modification and Immunomodulation in a Murine Prostate Cancer Model.

@en

type

Item

label

Role of Epigenetic Modification and Immunomodulation in a Murine Prostate Cancer Model.

@en

prefLabel

Role of Epigenetic Modification and Immunomodulation in a Murine Prostate Cancer Model.

@en

P1476

Role of Epigenetic Modification and Immunomodulation in a Murine Prostate Cancer Model

@en

P2093

Albert A Petrossian

http://www.w3.org/2001/XMLSchema#string

Ekaterine Goliadze

http://www.w3.org/2001/XMLSchema#string

Georgi Guruli

http://www.w3.org/2001/XMLSchema#string

Jay E Sulek

http://www.w3.org/2001/XMLSchema#string

Masoud H Manjili

http://www.w3.org/2001/XMLSchema#string

Samuel P Robinson

http://www.w3.org/2001/XMLSchema#string

Shaoqing Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism of action of lenalidomide in hematological malignancies

Phase I combination trial of lenalidomide and azacitidine in patients with higher-risk myelodysplastic syndromes.

Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia.

Lenalidomide induces immunomodulation in chronic lymphocytic leukemia and enhances antitumor immune responses mediated by NK and CD4 T cells.

Dendritic cell-based immunotherapy for prostate cancer.

Epigenetic changes in prostate cancer: implication for diagnosis and treatment.

Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women

Cancer/Testis Antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy.

Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial.

Lenalidomide modulates IL-8 and anti-prostate antibody levels in men with biochemically recurrent prostate cancer.

P304

361-373

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.23275

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Amir A Toor

P577

2016-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27862100

http://www.w3.org/2001/XMLSchema#string

Role of Epigenetic Modification and Immunomodulation in a Murine Prostate Cancer Model.

about

P2860

P2860

Role of Epigenetic Modification and Immunomodulation in a Murine Prostate Cancer Model.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698